Annual Accounts Payable
$1.06 M
+$832.90 K+370.18%
August 31, 2024
Summary
- As of February 26, 2025, LEXX annual accounts payable is $1.06 million, with the most recent change of +$832.90 thousand (+370.18%) on August 31, 2024.
- During the last 3 years, LEXX annual accounts payable has risen by +$953.00 thousand (+908.48%).
- LEXX annual accounts payable is now at all-time high.
Performance
LEXX Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$262.10 K
-$795.80 K-75.22%
November 30, 2024
Summary
- As of February 26, 2025, LEXX quarterly accounts payable is $262.10 thousand, with the most recent change of -$795.80 thousand (-75.22%) on November 30, 2024.
- Over the past year, LEXX quarterly accounts payable has stayed the same.
- LEXX quarterly accounts payable is now -75.22% below its all-time high of $1.06 million, reached on August 31, 2024.
Performance
LEXX Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
LEXX Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +370.2% | 0.0% |
| 3 y3 years | +908.5% | +13.5% |
| 5 y5 years | +3258.4% | +13.5% |
LEXX Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +908.5% | -75.2% | +449.5% |
| 5 y | 5-year | at high | +3258.4% | -75.2% | +1963.8% |
| alltime | all time | at high | >+9999.0% | -75.2% | >+9999.0% |
Lexaria Bioscience Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Nov 2024 | - | $262.10 K(-75.2%) |
| Aug 2024 | $1.06 M(+370.2%) | $1.06 M(+772.1%) |
| May 2024 | - | $121.30 K(+154.3%) |
| Feb 2024 | - | $47.70 K(-48.2%) |
| Nov 2023 | - | $92.10 K(-59.1%) |
| Aug 2023 | $225.00 K(+87.3%) | $225.00 K(-77.7%) |
| May 2023 | - | $1.01 M(+461.1%) |
| Feb 2023 | - | $180.10 K(-22.0%) |
| Nov 2022 | - | $230.90 K(+92.3%) |
| Aug 2022 | $120.10 K(+14.5%) | $120.10 K(+33.4%) |
| May 2022 | - | $90.00 K(+47.8%) |
| Feb 2022 | - | $60.90 K(-64.8%) |
| Nov 2021 | - | $172.90 K(+64.8%) |
| Aug 2021 | $104.90 K(+132.6%) | $104.90 K(-36.0%) |
| May 2021 | - | $163.80 K(+21.7%) |
| Feb 2021 | - | $134.60 K(+959.8%) |
| Nov 2020 | - | $12.70 K(-71.8%) |
| Aug 2020 | $45.10 K(+43.2%) | $45.10 K(+5.4%) |
| May 2020 | - | $42.80 K(-23.0%) |
| Feb 2020 | - | $55.60 K(-37.7%) |
| Nov 2019 | - | $89.30 K(+183.5%) |
| Aug 2019 | $31.50 K(+118.8%) | $31.50 K(-64.0%) |
| May 2019 | - | $87.40 K(+236.2%) |
| Feb 2019 | - | $26.00 K(-76.0%) |
| Nov 2018 | - | $108.30 K(+652.1%) |
| Aug 2018 | $14.40 K(-55.8%) | $14.40 K(-77.0%) |
| May 2018 | - | $62.50 K(-1.4%) |
| Feb 2018 | - | $63.40 K(+5.8%) |
| Nov 2017 | - | $59.90 K(+83.7%) |
| Aug 2017 | $32.60 K(-63.8%) | $32.60 K(+150.8%) |
| May 2017 | - | $13.00 K(-50.0%) |
| Feb 2017 | - | $26.00 K(-64.8%) |
| Nov 2016 | - | $73.90 K(-17.9%) |
| Aug 2016 | $90.00 K | $90.00 K(+36.8%) |
| May 2016 | - | $65.80 K(+42.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Feb 2016 | - | $46.10 K(-33.9%) |
| Nov 2015 | - | $69.70 K(+110.6%) |
| Aug 2015 | $33.10 K(-64.6%) | $33.10 K(-45.6%) |
| May 2015 | - | $60.80 K(+67.0%) |
| Feb 2015 | - | $36.40 K(-66.7%) |
| Nov 2014 | - | $109.40 K(-27.0%) |
| Aug 2014 | $93.60 K(-31.3%) | - |
| Jul 2014 | - | $149.90 K(+11.5%) |
| Apr 2014 | - | $134.40 K(-27.8%) |
| Jan 2014 | - | $186.20 K(+36.6%) |
| Oct 2013 | $136.30 K(+103.4%) | $136.30 K(+38.9%) |
| Jul 2013 | - | $98.10 K(+6.2%) |
| Apr 2013 | - | $92.40 K(+19.4%) |
| Jan 2013 | - | $77.40 K(+15.5%) |
| Oct 2012 | $67.00 K(-79.2%) | $67.00 K(-63.2%) |
| Jul 2012 | - | $182.00 K(-7.7%) |
| Apr 2012 | - | $197.10 K(+61.4%) |
| Jan 2012 | - | $122.10 K(-62.1%) |
| Oct 2011 | $322.30 K(+134.6%) | $322.30 K(+249.2%) |
| Jul 2011 | - | $92.30 K(-8.3%) |
| Apr 2011 | - | $100.60 K(-39.8%) |
| Jan 2011 | - | $167.10 K(+21.6%) |
| Oct 2010 | $137.40 K(+4988.9%) | $137.40 K(+4988.9%) |
| Oct 2008 | $2700.00(-86.1%) | $2700.00(-86.2%) |
| Jul 2008 | - | $19.50 K(-6.7%) |
| Apr 2008 | - | $20.90 K(-82.6%) |
| Jan 2008 | - | $120.10 K(+519.1%) |
| Oct 2007 | $19.40 K(+1041.2%) | $19.40 K(+397.4%) |
| Jul 2007 | - | $3900.00(-82.2%) |
| Apr 2007 | - | $21.90 K(+7200.0%) |
| Jan 2007 | - | $300.00(-82.4%) |
| Oct 2006 | $1700.00(+41.7%) | $1700.00(-91.2%) |
| Jul 2006 | - | $19.30 K(-32.0%) |
| Apr 2006 | - | $28.40 K(+6.0%) |
| Jan 2006 | - | $26.80 K |
| Oct 2005 | $1200.00 | - |
FAQ
- What is Lexaria Bioscience annual accounts payable?
- What is the all time high annual accounts payable for Lexaria Bioscience?
- What is Lexaria Bioscience annual accounts payable year-on-year change?
- What is Lexaria Bioscience quarterly accounts payable?
- What is the all time high quarterly accounts payable for Lexaria Bioscience?
- What is Lexaria Bioscience quarterly accounts payable year-on-year change?
What is Lexaria Bioscience annual accounts payable?
The current annual accounts payable of LEXX is $1.06 M
What is the all time high annual accounts payable for Lexaria Bioscience?
Lexaria Bioscience all-time high annual accounts payable is $1.06 M
What is Lexaria Bioscience annual accounts payable year-on-year change?
Over the past year, LEXX annual accounts payable has changed by +$832.90 K (+370.18%)
What is Lexaria Bioscience quarterly accounts payable?
The current quarterly accounts payable of LEXX is $262.10 K
What is the all time high quarterly accounts payable for Lexaria Bioscience?
Lexaria Bioscience all-time high quarterly accounts payable is $1.06 M
What is Lexaria Bioscience quarterly accounts payable year-on-year change?
Over the past year, LEXX quarterly accounts payable has changed by $0.00 (0.00%)